Penta Valent Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Penta Valent Tbk. trades at Rp322 (market cap 572.06B, 572.4K 24h volume), while Prodia Diagnostic Line Tbk trades at Rp262 (market cap 470.58B, 9.89M 24h volume). The key difference: Penta Valent Tbk. is the larger of the two by market cap, and Prodia Diagnostic Line Tbk is more actively traded (9.89M versus 572.4K). Which is the better fit depends on your goals.
| PEVE | PRDL | |
|---|---|---|
Market Cap | 572.06B | 470.58B |
Volume | 572.4K | 9.89M |
Lot | 5.72K | 98.86K |
Turnover | 184.34M | 2.6B |
Average Price | 322.04 | 263.04 |
Value | 184.34M | 2.6B |
Indicative Equilibrium Price | 324 | 272 |
Indicative Equilibrium Volume | 5K | 418 |
Trailing returns across standard periods
Latest headlines on both assets
PT Penta Valent Tbk (the Company) was established in 1968 in Jakarta, Indonesia under the name of CV Penta Valent, hereinafter, based on Notarial Deed No. 48 of Bebasa Daeng Lalo, S.H., dated August 16, 1972. The Company started its commercial operations in 1968. PT Tancorp Global Sentosa, a company incorporated in Indonesia, is the ultimate parent entity of the Company.
Read more on PEVE →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →